EU Tobacco Control Facing Challenges: Smoking Rate Decline Not Meeting Expectations

Regulations by 2FIRSTS.ai
Jul.17.2024
EU Tobacco Control Facing Challenges: Smoking Rate Decline Not Meeting Expectations
EU faces challenges in reducing smoking rates, with only a 1% decrease in smokers over three years.

According to Bulgarians reported on July 16, the EU's efforts to control smoking are facing challenges as the decrease in smoking rates has not met expectations. According to the latest study by the European Commission, the proportion of smokers in the EU has only decreased by 1 percentage point in the past three years, with currently 24% of the population still smoking; this data indicates that the EU is making slow progress in achieving its goal of reducing the number of smokers.


In the European Union, Bulgaria, Greece, and Croatia have smoking rates exceeding 35%, while Sweden has a smoking rate of less than 10%, making it the country with the lowest smoking rate. This highlights the differences and challenges among member states in implementing tobacco control measures.


Despite a decrease in smoking rates, packaged cigarettes remain the preferred choice for smokers, with the average daily consumption for smokers staying around 14 cigarettes per day compared to 2020, showing no significant decrease.


Meanwhile, the use of e-cigarettes is gradually becoming popular among young people, with 3% of respondents stating that they have used such products, especially in the 15 to 39 age group. The survey found that one-third of e-cigarette users started using them because of the influence of friends, while 36% of users did so to reduce or quit consumption of traditional tobacco.


As part of the European Cancer Plan, the EU has set a goal to achieve a "smoke-free generation" by 2040, with the proportion of tobacco users dropping to below 5%.


Belgian Minister of Health Frank Vandenbroucke emphasized the need for further tobacco control measures in a statement, noting widespread public support for strengthening smoke-free policies. Vandenbroucke also expressed hopes for the next European Commission to quickly advance revisions to the Tobacco Products Directive. Currently, the latest version of the EU Tobacco Products Directive dates back to 2014 and has been revised multiple times to adapt to market changes, but the latest review has been delayed.


Lilia Olefir, director of Smoke-Free Partnership (SFP), is calling on the European Union to immediately resume the review of three directives concerning tobacco taxes, tobacco products, and advertising in order to address the health risks associated with tobacco consumption. She points out that tobacco consumption is the EU's largest avoidable health risk, resulting in approximately 700,000 deaths per year. Furthermore, Lilia Olefir emphasizes the importance of increasing the minimum tax rate on tobacco products, implementing mandatory plain packaging, prohibiting cross-border online sales, protecting youth from the influence of addictive product digital advertising, and calls on the EU to establish uniform regulations to intensify efforts to combat tobacco lobbying groups.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
On September 16, 2Firsts hosted a China-focused industry forum during InterTabac in Dortmund, bringing together more than 30 participants from North America, Europe, India, South Korea and other markets. The session covered traditional tobacco, next-generation products, exports, technology, regulation and supply chains, while examining how China’s tobacco sector operates, where its transformation may be heading, and why its growing role matters increasingly to companies across the global tobacco and nicotine industry.
Sep.21
New Zealand Associate Health Minister Casey Costello Warns on Illicit Cigarettes as Legal Tobacco Sales Halve Over Decade
New Zealand Associate Health Minister Casey Costello Warns on Illicit Cigarettes as Legal Tobacco Sales Halve Over Decade
New Zealand Associate Health Minister Casey Costello said legal tobacco sales in the country have fallen by more than half over the past decade, with sales declining more than 20% in 2025 compared with the previous year. She warned that the decline may not fully reflect lower smoking rates, as increased availability of illicit cigarettes could also be contributing. The government said it would continue strengthening tobacco and vape retail enforcement while monitoring the impact of illicit tobacco on public health and tax revenue.
Aug.26
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30
Kantar Study Finds More Than 93% of Vape Products in Ukraine Fail Regulatory Requirements
Kantar Study Finds More Than 93% of Vape Products in Ukraine Fail Regulatory Requirements
According to Interfax-Ukraine, a study conducted by market research firm Kantar Ukraine at the request of major tobacco companies found that more than 93% of vape products in Ukraine did not fully comply with regulatory requirements. The research examined product categories, brand distribution and consumer purchasing channels, showing that pod systems and disposable vapes represent major segments of the market, while offline retail remains the dominant purchasing channel. The findings highlight ongoing compliance challenges in Ukraine’s vape market.
Aug.26
Product | HQD SiSA 80K Enters the U.S. Market With a Hookah-Inspired Approach to the High-Capacity Disposable Segment
Product | HQD SiSA 80K Enters the U.S. Market With a Hookah-Inspired Approach to the High-Capacity Disposable Segment
The HQD SiSA 80K Hookah Disposable Vape has appeared across U.S. and cross-border online retail channels. The device comes prefilled with 28ml of e-liquid, uses a 5% nicotine salt configuration and carries a brand claim of up to 80,000 puffs. Beyond puff count, the product differentiates itself through hookah-inspired features including adjustable airflow, a flowing-water sound effect and flavor options associated with traditional hookah consumption.
Aug.18